Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management

Monoclonal antibodies have become a mainstay in the treatment of patients with relapsing multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS. They are highly precise by specifically targeting molecules displayed on cells involved in distinct immune mechanisms of...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajnc, Nik, Bsteh, Gabriel, Berger, Thomas, Mares, Jan, Hartung, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978776/
https://www.ncbi.nlm.nih.gov/pubmed/35378683
http://dx.doi.org/10.1007/s13311-022-01224-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978776/
https://www.ncbi.nlm.nih.gov/pubmed/35378683
http://dx.doi.org/10.1007/s13311-022-01224-9

Ejemplares similares